Isolated Pierre Robin sequence

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:718OMIM:261800Q87.0
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Isolated Pierre Robin sequence (PRS), also known as Pierre Robin syndrome or Robin sequence, is a congenital condition characterized by a triad of clinical features present at birth: micrognathia (an abnormally small lower jaw), glossoptosis (backward displacement or retraction of the tongue), and often a U-shaped cleft palate. The term 'sequence' reflects the understanding that these features arise in a cascade — the primary defect is mandibular hypoplasia occurring early in fetal development, which prevents the tongue from descending normally, and the posteriorly positioned tongue then physically obstructs palatal shelf closure, resulting in the characteristic wide, U-shaped cleft palate. The 'isolated' designation distinguishes this form from syndromic cases where Pierre Robin sequence occurs as part of a broader genetic syndrome such as Stickler syndrome or velocardiofacial syndrome. The condition primarily affects the craniofacial and upper airway systems. Neonates with isolated PRS frequently experience significant upper airway obstruction due to the combination of the small jaw and posteriorly displaced tongue, which can lead to breathing difficulties ranging from mild to life-threatening. Feeding difficulties are also very common, as the anatomical abnormalities interfere with effective sucking and swallowing, potentially leading to failure to thrive. Obstructive sleep apnea is a frequent complication. Recurrent otitis media and conductive hearing loss may also occur, particularly in those with cleft palate. Management of isolated PRS is multidisciplinary and depends on the severity of airway compromise and feeding difficulties. Mild cases may be managed conservatively with prone positioning to allow gravity to bring the tongue forward and relieve airway obstruction, along with specialized feeding techniques and devices. Moderate to severe airway obstruction may require nasopharyngeal airway placement, tongue-lip adhesion surgery, or mandibular distraction osteogenesis — a surgical procedure that gradually lengthens the mandible. In the most severe cases, tracheostomy may be necessary. Cleft palate repair is typically performed surgically between 9 and 18 months of age. With appropriate management, many children with isolated PRS experience significant catch-up mandibular growth during the first few years of life, and the prognosis for long-term development is generally favorable.

Also known as:

Clinical phenotype terms— hover any for plain English:

Upper airway obstructionHP:0002781Subglottic stenosisHP:0001607Cor pulmonaleHP:0001648Tracheal stenosisHP:0002777TracheomalaciaHP:0002779BronchomalaciaHP:0002780Elevated pulmonary artery pressureHP:0004890
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

10 events
Dec 2026Pharmacogenetics of Response to Sitagliptin (PRS)

University of Maryland, Baltimore — PHASE4

TrialNOT YET RECRUITING
Mar 2026Effectiveness and Safety of OviTex® PRS in Breast Reconstruction

Tela Bio Inc — NA

TrialNOT YET RECRUITING
Jan 2026Leica Microsystems Sponsored Study to Collect and Confirm Clinical Data on the Performance of the GLOW800 Device When Used in Accordance With Its Intended Use.

Leica Microsystems (Schweiz) AG

TrialRECRUITING
Oct 2025Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health

Massachusetts General Hospital — NA

TrialRECRUITING
Oct 2025REMIMID-ICU: Remimazolam vs Midazolam for Deep Sedation in Hemodynamically Unstable, Mechanically Ventilated Adults

Yancheng First People's Hospital — PHASE3

TrialNOT YET RECRUITING
May 2025Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistical Pilot Study

HudsonAlpha Institute for Biotechnology — NA

TrialRECRUITING
Apr 2025Polygenic Risk Driven Pragmatic Statin Trial for Heart Disease Prevention

Mikk JÜRISSON — PHASE4

TrialENROLLING BY INVITATION
Jan 20233D-CT-Based Prediction of Difficult Laryngoscopy in Infants With Pierre Robin Sequence

Nanjing Children's Hospital

TrialACTIVE NOT RECRUITING
Oct 2022Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)

Fox Chase Cancer Center — PHASE3

TrialRECRUITING
Sep 2022A Retrospective Assessment of OviTex PRS (OviTex)

Tela Bio Inc

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Isolated Pierre Robin sequence.

View clinical trials →

No actively recruiting trials found for Isolated Pierre Robin sequence at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Isolated Pierre Robin sequence community →

No specialists are currently listed for Isolated Pierre Robin sequence.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Isolated Pierre Robin sequence.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Isolated Pierre Robin sequenceForum →

No community posts yet. Be the first to share your experience with Isolated Pierre Robin sequence.

Start the conversation →

Latest news about Isolated Pierre Robin sequence

Disease timeline:

New recruiting trial: A Retrospective Assessment of OviTex PRS (OviTex)

A new clinical trial is recruiting patients for Isolated Pierre Robin sequence

New recruiting trial: Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistical Pilot Study

A new clinical trial is recruiting patients for Isolated Pierre Robin sequence

New recruiting trial: Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health

A new clinical trial is recruiting patients for Isolated Pierre Robin sequence

New recruiting trial: Leica Microsystems Sponsored Study to Collect and Confirm Clinical Data on the Performance of the GLOW800 Device When Used in Accordance With Its Intended Use.

A new clinical trial is recruiting patients for Isolated Pierre Robin sequence

New recruiting trial: Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)

A new clinical trial is recruiting patients for Isolated Pierre Robin sequence

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Isolated Pierre Robin sequence

What is Isolated Pierre Robin sequence?

Isolated Pierre Robin sequence (PRS), also known as Pierre Robin syndrome or Robin sequence, is a congenital condition characterized by a triad of clinical features present at birth: micrognathia (an abnormally small lower jaw), glossoptosis (backward displacement or retraction of the tongue), and often a U-shaped cleft palate. The term 'sequence' reflects the understanding that these features arise in a cascade — the primary defect is mandibular hypoplasia occurring early in fetal development, which prevents the tongue from descending normally, and the posteriorly positioned tongue then physi

At what age does Isolated Pierre Robin sequence typically begin?

Typical onset of Isolated Pierre Robin sequence is neonatal. Age of onset can vary across affected individuals.